In December 1999, the intramuscular (IM) route for the drug Erwinia L-Asparaginase was adopted in paediatric oncology units in the light of pharmacokinetic data...
A children’s oncology unit in the UK carried out an initial audit of the information given by healthcare professionals to children, families, teachers and...
